Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary E Gallick

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
SRC as a potential therapeutic target in solid tumor oncologyGary E Gallick
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Treatment for advanced tumors: SRC reclaims center stageJustin M Summy, Gary E Gallick
Cancer Metastasis Reviews|July 30, 2003
Src family kinases in tumor progression and metastasisJustin M Summy, Gary E Gallick
Anti-Cancer Drugs|March 14, 2007
Src, chemoresistance and epithelial to mesenchymal transition: are they related?Ami N Shah, Gary E Gallick
Anti-Cancer Agents in Medicinal Chemistry|November 30, 2007
SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapyFaye M Johnson, Gary E Gallick
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Gemcitabine resistance in pancreatic cancer: picking the key playersMichael P Kim, Gary E Gallick
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Src continues aging: current and future clinical directionsScott Kopetz, Ami N Shah, Gary E Gallick
International Journal of Cancer|March 3, 2011
Steps in prostate cancer progression that lead to bone metastasisJung-Kang Jin, Farshid Dayyani, Gary E Gallick
Mini Reviews in Medicinal Chemistry|June 22, 2006
SRC inhibitors as potential therapeutic agents for human cancersJose G Trevino, Justin M Summy, Gary E Gallick
Clinical & Experimental Metastasis|November 7, 2006
Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cellsMeghan E Minard, Lee M Ellis, Gary E Gallick
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
SRC as a potential therapeutic target in solid tumor oncologyGary E Gallick
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Treatment for advanced tumors: SRC reclaims center stageJustin M Summy, Gary E Gallick
Cancer Metastasis Reviews|July 30, 2003
Src family kinases in tumor progression and metastasisJustin M Summy, Gary E Gallick
Anti-Cancer Drugs|March 14, 2007
Src, chemoresistance and epithelial to mesenchymal transition: are they related?Ami N Shah, Gary E Gallick
Anti-Cancer Agents in Medicinal Chemistry|November 30, 2007
SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapyFaye M Johnson, Gary E Gallick
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Gemcitabine resistance in pancreatic cancer: picking the key playersMichael P Kim, Gary E Gallick
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Src continues aging: current and future clinical directionsScott Kopetz, Ami N Shah, Gary E Gallick
International Journal of Cancer|March 3, 2011
Steps in prostate cancer progression that lead to bone metastasisJung-Kang Jin, Farshid Dayyani, Gary E Gallick
Mini Reviews in Medicinal Chemistry|June 22, 2006
SRC inhibitors as potential therapeutic agents for human cancersJose G Trevino, Justin M Summy, Gary E Gallick
Clinical & Experimental Metastasis|November 7, 2006
Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cellsMeghan E Minard, Lee M Ellis, Gary E Gallick
Pageof 12